CDKN2A and chondrosarcoma: Further analysis of 3/21 dedifferentiated chondrosarcomas where material was available/suitable for analysis, there was normal diploid p16/CDKN2A copy number in the well-differentiated component and p16/CDKN2A loss in the dedifferentiated component.